{
    "N/R/U": null,
    "Applicant": "Ferring Pharmaceuticals Inc.",
    "BLA Number": "21289",
    "Proprietary Name": "Bravelle",
    "Proper Name": "urofollitropin",
    "BLA Type": "351(a)",
    "Strength": "75IU ",
    "Dosage Form": "For Injection",
    "Route of Administration": "Subcutaneous, Intramuscular",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "6-May-02",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "2112",
    "Product Number": "1",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}